AI-enabled discovery of small molecule β-lactamase inhibitors to overcome enzyme diversity and resistance evolution.
Artificial intelligence (AI) is reshaping modern drug discovery by enabling data-driven exploration of chemical space, predictive modeling of molecular interactions, and multi-objective optimization of therapeutic candidates. These capabilities are particularly important in addressing antimicrobial resistance, where co...